Syncromune® is a pharmaceutical or biotechnology company that develops drug substances and drug products across clinical development and commercialization phases. The company specializes in complex therapeutics, including monoclonal antibodies and oligonucleotides, with expertise in advanced formulations such as co-formulations, multi-component products, and conjugates. Syncromune® operates a global network of contract development and manufacturing organizations (CDMOs) and contract testing laboratories (CTLs) to support their analytical development and manufacturing strategies. The company is focused on bringing innovative therapeutics to market while maintaining strict compliance with cGMP, ICH, and FDA regulatory guidelines.
Industry
Pharmaceutical/Biotechnology
Remote Policy
Hybrid
Beta · Sourced from candidate reports
Be the first to share your experience with Syncromune®.
Your reply helps other candidates know what to expect.
